Adejumo, Adeyinka Charles; Labonté, Patrick 
ORCID: https://orcid.org/0000-0001-7262-3125 et Bukong, Terence Ndonyi ORCID: https://orcid.org/0000-0003-3898-0617
(2021).
Relationship Between Recreational Cannabis Use and Helicobacter pylori Infection
Cannabis Cannabinoid Reserch
.
DOI: 10.1089/can.2021.0139.
(Sous Presse)
Résumé
Background: Cannabis plant extracts suppress gastric acid secretion and inflammation, and promote gastroduodenal ulcer healing, all of which are triggered by Helicobacter Pylori infection (HPI). Here, we evaluate the association between cannabis use and HPI among a representative community sample. Materials and Methods: We identified respondents who completed cannabis use questions and were tested for HPI (H. pylori IgG antibody seropositivity) from the National Health and Nutrition Examination Survey III dataset (n=4556). Cannabis usage was categorized as ever-use (ever, never), cumulative lifetime use (>10-times, 1-10-times, never), or recent use (>31-days-ago, within-31-days, never). We calculated the crude and adjusted risk (prevalence rate ratio, cPRR and aPRR) of having HPI with cannabis use using generalized Poisson models (SAS 9.4). The models were adjusted for demographics and risk factors for HPI. Results: The prevalence of HPI was lower among ever versus never cannabis users (18.6% vs. 33%, p<0.0001). Cannabis use was associated with a decreased risk of HPI (cPRR: 0.56 confidence interval [95% CI: 0.47-0.67]; p<0.0001), which persisted after adjusting for demographics (aPRR: 0.75 [95% CI: 0.63-0.90]; p=0.0016) and comorbidities (aPRR: 0.79 [95% CI: 0.66-0.95]; p=0.0145). Further, individuals with >10-times lifetime cannabis use had a decreased risk of HPI compared with those with 1-10-times lifetime use (aPRR: 0.70 [95% CI: 0.55-0.89]; p=0.0011) and never-users (aPRR: 0.65 [95% CI: 0.50-0.84]; p=0.0002). Conclusion: Recreational cannabis use is associated with diminished risk of HPI. These observations suggest the need for additional research assessing the effects of medical cannabis formulations on HPI.
| Type de document: | Article |
|---|---|
| Mots-clés libres: | antibiotic resistance; cannabinoids; concomitant; peptic ulcer disease; prevalence |
| Centre: | Centre INRS-Institut Armand Frappier |
| Date de dépôt: | 22 juin 2022 19:18 |
| Dernière modification: | 22 juin 2022 19:18 |
| URI: | https://espace.inrs.ca/id/eprint/12275 |
Gestion Actions (Identification requise)
 |
Modifier la notice |